NECTIN3 and cancer: In particular, in different cancer types (ovarian carcinoma, nasopharyngeal carcinoma, prostate carcinoma and lung adenocarcinoma), the altered expression of PVRL3 has been observed to contribute to the invasive capacity of tumor cells, facilitating their dissemination to other tissues and leading to a worse prognosis [12,13,14,15].